PSI Stories
New nuclear medicine therapy successfully tested
A promising radiopharmaceutical against metastatic neuroendocrine tumours – developed at the Paul Scherrer Institute PSI – has been successfully tested.
Ideas with flair
The research carried out at PSI tends to be extremely complex and often difficult to describe. We gave researchers a tricky assignment: Sketch the basic idea of your research in a simple drawing.
Protons and other particles: The HIPA facility turns 50
Since 1974 HIPA has been accelerating protons for research.
Highlights – PSI research in 2023
A look back over the past 12 months.
„IMPACT is very important in terms of international competition“
Daniela Kiselev talks about the upgrade planned at PSI's proton accelerator facility.
Repairing genetic damage with sunlight
An international research team at SwissFEL of PSI has discovered how an enzyme repairs DNA damage with the help of sunlight.
Smart glass and music from SLS
Every year the PSI Founder Fellowship Programme supports new ideas for innovative applications with up to 150,000 Swiss francs.
How important is hydrogen for the energy transition?
Assessments by PSI energy expert Thomas J. Schmidt
Development of a Radioligand
Cristina Müller and her team are looking for a new means of visualising and further investigating the SARS-CoV-2 entry receptor using PET imaging techniques.
Grasping diseases by the roots
PSI researchers take pictures of cell nuclei using modern high-resolution imaging techniques, employ learning algorithms to comb through these data, and thus can more reliably identify anomalies.